Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -26.399\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a. Cc1ccc(Nc2nc(NCCO)c3ccccc3n2)cc1C.Cl
b. O=C(O)c1cccc(NC(=O)c2cn(-c3ccccc3)nc2-c2cccc(Br)c2)c1
c. O=C(Cn1nnc(-c2ccccc2)n1)OC1CCOC1=O
d. O=C(c1ccc(-n2cncn2)c([N+](=O)[O-])c1)N1CCN(S(=O)(=O)c2ccc(Cl)cc2)CC1
e. CC(C)N1CCC(N2CCN(Cc3ccc(-c4ccccc4Cl)o3)CC2CCO)CC1
Answer: e. CC(C)N1CCC(N2CCN(Cc3ccc(-c4ccccc4Cl)o3)CC2CCO)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)N1CCC(N2CCN(Cc3ccc(-c4ccccc4Cl)o3)CC2CCO)CC1
CC(C)N1CCC(N2CCN(Cc3ccc(-c4ccccc4Cl)o3)CC2CCO)CC1
2-[4-[[5-(2-chlorophenyl)furan-2-yl]methyl]-1-(1-propan-2-ylpiperidin-4-yl)piperazin-2-yl]ethanol